TECHNICAL FIELD
The present invention relates to a beta-alanine derivative, pharmaceutically acceptable salts thereof, and a pharmaceutical composition including the same as an active ingredient.
BACKGROUND ART
Metabolic syndrome widely occurring around the world includes diabetes, hypertension,
FIELD OF THE INVENTION
The present invention relates to constrained cyano compounds and to their use as selective inhibitors of post-proline/alanine cleaving amino-dipeptidases. The invention further relates to methods of employing such inhibitors, alone or with another therapeutic agent, to treat